Published in J Korean Med Sci on September 01, 2013
Self-correction in biomedical publications and the scientific impact. Croat Med J (2014) 1.44
The Pressure to Publish More and the Scope of Predatory Publishing Activities. J Korean Med Sci (2016) 1.32
Preserving the Integrity of Citations and References by All Stakeholders of Science Communication. J Korean Med Sci (2015) 0.94
Systematic and open identification of researchers and authors: focus on open researcher and contributor ID. J Korean Med Sci (2014) 0.85
Reference accuracy: authors', reviewers', editors', and publishers' contributions. J Korean Med Sci (2014) 0.80
Specialist Bibliographic Databases. J Korean Med Sci (2016) 0.75
Essential Components of Educational Programs on Biomedical Writing, Editing, and Publishing. J Korean Med Sci (2015) 0.75
Researcher and Author Profiles: Opportunities, Advantages, and Limitations. J Korean Med Sci (2017) 0.75
Citation indexes for science; a new dimension in documentation through association of ideas. Science (1955) 11.50
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J (2007) 7.45
Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA (2009) 4.48
Biomedical journal editing: elements of success. Croat Med J (2011) 3.06
Three options for citation tracking: Google Scholar, Scopus and Web of Science. Biomed Digit Libr (2006) 3.01
Korean association of medical journal editors at the forefront of improving the quality and indexing chances of its member journals. J Korean Med Sci (2013) 2.34
EMBASE versus MEDLINE for family medicine searches: can MEDLINE searches find the forest or a tree? Can Fam Physician (2005) 2.09
Identifying clinical trials in the medical literature with electronic databases: MEDLINE alone is not enough. Control Clin Trials (2000) 2.07
Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int (2011) 2.05
Bradford's law and the bibliography of science. Nature (1969) 1.86
Comparing test searches in PubMed and Google Scholar. J Med Libr Assoc (2007) 1.74
Medline and Embase complement each other in literature searches. BMJ (1998) 1.73
Is the coverage of Google Scholar enough to be used alone for systematic reviews. BMC Med Inform Decis Mak (2013) 1.60
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int (2011) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Performance of online biomedical databases in rheumatology. J Rheumatol (1994) 1.42
Detecting plagiarism: Google could be the way forward. BMJ (2006) 1.39
Bibliographic databases: some critical points. J Korean Med Sci (2013) 0.92
Journal quality and visibility: Is there a way out of the scientific periphery? Prilozi (2006) 0.90
Croatian Medical Journal citation score in Web of Science, Scopus, and Google Scholar. Croat Med J (2010) 0.87
Current Contents Connect and PubMed--a comparison of content and currency. Health Info Libr J (2002) 0.80
Automation in the library. Hosp Prog (1966) 0.79
Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des (2011) 4.16
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Biomedical journal editing: elements of success. Croat Med J (2011) 3.06
Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol (2005) 2.28
Diversity, value and limitations of the journal impact factor and alternative metrics. Rheumatol Int (2011) 2.05
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int (2011) 1.59
Best peer reviewers and the quality of peer review in biomedical journals. Croat Med J (2012) 1.54
Authorship problems in scholarly journals: considerations for authors, peer reviewers and editors. Rheumatol Int (2012) 1.52
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Self-correction in biomedical publications and the scientific impact. Croat Med J (2014) 1.44
Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J (2013) 1.40
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther (2009) 1.39
Open access: changing global science publishing. Croat Med J (2013) 1.38
Obesity in rheumatoid arthritis. Rheumatology (Oxford) (2010) 1.32
Upgrading instructions for authors of scholarly journals. Croat Med J (2014) 1.31
Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol (2009) 1.30
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-α therapy. Rheumatol Int (2010) 1.28
Promoting transparent and accurate reporting of research studies in rheumatology: endorsement of reporting guidelines in rheumatology journals. Semin Arthritis Rheum (2013) 1.23
Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis (2009) 1.22
The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J (2010) 1.21
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factors. J Health Psychol (2005) 1.20
Association of interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis (2008) 1.19
Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 1.16
Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. Antioxid Redox Signal (2010) 1.13
Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med (2005) 1.13
Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int (2011) 1.12
Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2008) 1.11
Inverted BMI rather than BMI is a better proxy for percentage of body fat. Ann Hum Biol (2011) 1.11
Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol (2010) 1.11
The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol (2010) 1.10
Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther (2012) 1.09
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. Br J Health Psychol (2007) 1.05
Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. Ann Rheum Dis (2012) 1.01
Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium (2008) 0.99
The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.99
Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther (2008) 0.99
Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol (2010) 0.99
The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum (2013) 0.97
The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther (2011) 0.96
An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis. Chest (2005) 0.95
Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 0.95
Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis. Arthritis Rheum (2009) 0.94
Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J (2010) 0.94
Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther (2011) 0.94
Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) (2013) 0.93
Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets (2010) 0.92
Randomised, double-blind controlled trial by dose reduction of implanted intrathecal morphine delivery in chronic non-cancer pain. BMJ Open (2013) 0.91
Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis (2013) 0.91
Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis (2010) 0.91
Dyslipidaemia in rheumatological autoimmune diseases. Open Cardiovasc Med J (2011) 0.90
Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology (Oxford) (2014) 0.89
Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation. Clin Rheumatol (2010) 0.89
Arterial hypertension assessed "out-of-office" in a contemporary cohort of rheumatoid arthritis patients free of cardiovascular disease is characterized by high prevalence, low awareness, poor control and increased vascular damage-associated "white coat" phenomenon. Arthritis Res Ther (2013) 0.87
Familial mediterranean Fever as an emerging clinical model of atherogenesis associated with low-grade inflammation. Open Cardiovasc Med J (2010) 0.87
Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev (2013) 0.87
Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research. Curr Pharm Des (2012) 0.87
Free radicals and redox signalling in T-cells during chronic inflammation and ageing. Biochem Soc Trans (2011) 0.87
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. J Rheumatol (2005) 0.86
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade. Clin Rheumatol (2014) 0.86
Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis. Nat Rev Rheumatol (2012) 0.85
Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther (2008) 0.85
Suprarenal graft fixation in endovascular abdominal aortic aneurysm repair is associated with a decrease in renal function. J Vasc Surg (2012) 0.85
Endothelial dysfunction as a determinant of trastuzumab-mediated cardiotoxicity in patients with breast cancer. Anticancer Res (2014) 0.84
Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther (2012) 0.84
Rheumatoid arthritis: is it a coronary heart disease equivalent? Curr Opin Cardiol (2011) 0.84
Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis? Angiology (2010) 0.84
A randomized controlled trial of a cognitive behavioural patient education intervention vs a traditional information leaflet to address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford) (2012) 0.84
Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis. Curr Med Chem (2015) 0.83
Homocysteine from endothelial cells promotes LDL nitration and scavenger receptor uptake. Free Radic Biol Med (2005) 0.83
Fostering autonomous motivation, physical activity and cardiorespiratory fitness in rheumatoid arthritis: protocol and rationale for a randomised control trial. BMC Musculoskelet Disord (2014) 0.83
Prevalence and predictors of ocular manifestations of RA: is there a need for routine screening? Musculoskeletal Care (2007) 0.82
Abdominal aortic aneurysm: a review of the genetic basis. Angiology (2010) 0.82
Galectin-2 (LGALS2) 3279C/T polymorphism may be independently associated with diastolic blood pressure in patients with rheumatoid arthritis. Clin Exp Hypertens (2009) 0.82
'All singing from the same hymn sheet': healthcare professionals' perceptions of developing patient education material about the cardiovascular aspects of rheumatoid arthritis. Musculoskeletal Care (2009) 0.81
Platelets in rheumatic diseases: friend or foe? Curr Pharm Des (2014) 0.81
Validation of a novel ELISA for measurement of MDA-LDL in human plasma. Free Radic Biol Med (2003) 0.81
Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms. Curr Vasc Pharmacol (2011) 0.81
Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model. Rheumatol Int (2013) 0.80
Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. Arthritis Res Ther (2013) 0.80
Adherence to medication. N Engl J Med (2005) 0.80
Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. Semin Arthritis Rheum (2013) 0.80
Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis. J Rheumatol (2011) 0.80
Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) (2014) 0.80
The health and life experiences of mothers with rheumatoid arthritis: a phenomenological study. Musculoskeletal Care (2007) 0.80
Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence. Angiology (2009) 0.80
Development and initial validation of a heart disease knowledge questionnaire for people with rheumatoid arthritis. Patient Educ Couns (2009) 0.79
Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. BMC Musculoskelet Disord (2012) 0.79
The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.79
Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 0.79